A Study of ONO-7475 in Patients With Acute Leukemias

Clinical trial NCT03176277 · TERMINATED

Trial details

NCT number: NCT03176277
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Leukemia Myelodysplastic Syndromes

Start date: 2017-06-26
Primary completion: 2022-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.